Pinsent Masons recruits third partner in Amsterdam hiring life sciences specialist

03 Jun 2021 | 08:28 am | 1 min. read

Multinational law firm Pinsent Masons has recruited Life Sciences partner, Machteld Hiemstra in Amsterdam as it develops its Netherlands-based technology, science and industry (TSI) capabilities.

Machteld, who is the firm's third partner in The Netherlands, is a civil and regulatory litigator specialising in regulatory enforcement and compliance with an emphasis on medicines and medical devices regulatory mandates, consumer protection, GDPR, product liability and patent extension disputes.
A life sciences specialist, Machteld will advise on Pan-European and domestic matters including biologics and biotech, generics and biosimilars, medtech and digital health.
Amsterdam office head at Pinsent Masons, Wouter Seinen, said: "Building out capabilities that focus on life sciences regulatory advisory and disputes work will be a game changer for us in Amsterdam.
“Not only will Machteld's experience support the development of our global technology, science and industry sector, it will enable us to tap into opportunities prompted by the relocation of the European Medicines Association to Amsterdam as clients increasingly seek on the ground capabilities. Machteld's expertise will play an important role in adding strength and depth to our pan-European Life Sciences capabilities."
Machteld's hire follows the recruitment of TSI partner Alexander Spoor in May following the launch of Pinsent Masons' Amsterdam presence with the hire of office head Wouter Seinen in February.
Joining from Simmons & Simmons, Machteld has advised a number of high-profile businesses including GSK, Bayer, Abbott and Gilead. Her career incorporates both private practice and in-house experience working with Akzo Nobel as senior legal counsel between 2004 and 2007 where she was responsible for global pharma related product liability matters.
Commenting on her move, Machteld said: "Demand for domestic and international life sciences capabilities is increasing in Netherlands and across continental Europe. I am excited to be joining an international team with an established track record of using law as a business enabler for its clients.”

Latest press releases

Show me all press releases

Pinsent Masons hires co-head of its investor-state arbitration practice in London

Multinational law firm Pinsent Masons has hired partner Graham Coop to the firm’s international arbitration practice.

Pinsent Masons announces new Head of Melbourne to coincide with new Melbourne premises

Multinational law firm Pinsent Masons has announced a new Head of Melbourne, Phillipa Beck, which will coincide with a move for the firm’s Melbourne office to new premises in the heart of Melbourne’s CBD at 101 Collins Street in April.

Pinsent Masons advises IFC on landmark investment in Mongolia’s first ever green bond issuance

Multinational law firm Pinsent Masons has advised International Finance Corporation (IFC) on its investment in Mongolia’s first ever green bond issuance.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons appoints life sciences patent expert in its London office

Multinational law firm Pinsent Masons has hired European and UK life sciences partner Kristina Cornish into its London office.

Pinsent Masons advises UMS Consulting on its acquisition by Expleo

Multinational law firm Pinsent Masons has advised the shareholders of UMS Consulting GmbH & Co. KG on the sale of their shares to Expleo Group S.A.S.

Pinsent Masons Advises Accord Healthcare in Exclusive Licence Agreement with Myovant Sciences to Commercialise ORGOVYX® for Advanced Hormone-Sensitive Prostate Cancer in Europe

Pinsent Masons represented Accord Healthcare Ltd in an exclusive license agreement with Myovant Sciences to commercialise relugolix, Myovant’s advanced hormone-sensitive prostate cancer treatment, under the trade name ORGOVYX® in the European Economic Area, United Kingdom, Switzerland and Turkey.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.